Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma.

Saved in:

Bibliographic Details
Title:	Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma.
Authors:	Dreikhausen, Lena¹, Kusnik, Alexander^1,2, Schulte, Nadine¹, Eckardt, Maximilian¹, Teufel, Andreas^1,2, Gaiser, Timo³, Ebert, Matthias^1,2, Tianzuo Zhan¹ tianzuo.zhan@umm.de
Source:	Journal of Gastrointestinal & Liver Diseases. Sep2021, Vol. 30 Issue 3, p409-410. 2p.
Database:	Academic Search Ultimate

Description
ISSN:	18418724
DOI:	10.15403/jgld-3730